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Abstract
Biallelic variants in POLR3A cause 4H leukodystrophy, characterized by hypomyelination in combination with cerebellar and
pyramidal signs and variable non-neurological manifestations. Basal ganglia are spared in 4H leukodystrophy, and dystonia is not
prominent. Three patients with variants inPOLR3A, an atypical presentation with dystonia, andMR involvement of putamen and
caudate nucleus (striatum) and red nucleus have previously been reported. Genetic, clinical findings and 18MRI scans from nine
patients with homozygous or compound heterozygous POLR3A variants and predominant striatal changes were retrospectively
reviewed in order to characterize the striatal variant of POLR3A-associated disease. Prominent extrapyramidal involvement was
the predominant clinical sign in all patients. The three youngest children were severely affected with muscle hypotonia, impaired
head control, and choreic movements. Presentation of the six older patients was milder. Two brothers diagnosed with juvenile
parkinsonism were homozygous for the c.1771-6C >G variant in POLR3A; the other seven either carried c.1771-6C >G (n = 1)
or c.1771-7C >G (n = 7) together with another variant (missense, synonymous, or intronic). Striatal T2-hyperintensity and
atrophy together with involvement of the superior cerebellar peduncles were characteristic. Additional MRI findings were
involvement of dentate nuclei, hila, or peridentate white matter (3, 6, and 4/9), inferior cerebellar peduncles (6/9), red nuclei
(2/9), and abnormal myelination of pyramidal and visual tracts (6/9) but no frank hypomyelination. Clinical and MRI findings in
patients with a striatal variant of POLR3A-related disease are distinct from 4H leukodystrophy and associated with one of two
intronic variants, c.1771-6C >G or c.1771-7C >G, in combination with another POLR3A variant.
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Introduction
RNA polymerase III (POLR3) transcribes genes encoding
small, non-coding RNAs including tRNAs, 5S RNA, 7SK
RNA, and U6 small nuclear RNA, which are involved in the
regulation of transcription, RNA processing, and translation
[1].
Disease-causing variants in genes coding for POLR3 sub-
units were first discovered in patients with hypomyelinating
leukodystrophy. They are located in POLR3A [2] and
POLR3B [1, 3], which encode the largest and second largest
subunits of POLR3 forming the catalytic centre of the en-
zyme, as well as in POLR1C [4], a gene encoding a shared
POLR1 and POLR3 subunit. The resulting 4H leukodystro-
phy (hypomyelination, hypodontia, hypogonadotropic
hypogonadism) is characterized by hypomyelination in com-
bination with early cerebellar and subsequent pyramidal signs
(usually mild) and variable non-neurological manifestations,
namely dental and endocrine features as well as myopia [5].
Ataxia is the predominant clinical finding in 4H leukodystro-
phy. Dystonia is an additional, common, and initially under-
recognized feature in 4H leukodystrophy [6], but not
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prominent at disease onset, and basal ganglia abnormalities as
a potential correlate of dystonia have not been reported in 4H
leukodystrophy. Clinical manifestations and hypomyelination
in 4H leukodystrophy are more severe in patients with variants
in POLR3A and POLR1C than in patients with variants in
POLR3B [7, 8]; hypomyelination, however, is not obligatory,
and manifestation without hypomyelination occurs in patients
with variants in POLR3A or POLR3B [9].
During the last years, POLR3A variants without predomi-
nant ataxia have been reported: A striatal manifestation with
predominant dystonia and MR involvement of putamen, cau-
date and red nucleus due to a homozygous founder variant in
intron 13 was reported for three patients from two families
with a Roma background [10]. In addition, biallelic
POLR3A variants have been recognized as a cause of heredi-
tary spastic ataxia [11, 12].
In order to characterize the striatal variant of POLR3A-re-
lated disease, we reviewed clinical, genetic, and MRI findings
of nine patients with POLR3A variants and striatal changes.
Patients and methods
We retrospectively identified nine patients from eight families
with biallelic POLR3A variants and striatal changes on MRI
through the patient database at the Center for Childhood
White Matter Disorders Amsterdam. Patients were referred
to the Center for Childhood White Matter Disorders
Amsterdam after identification of POLR3Avariants, but with-
out typical presentation for 4H leukodystrophy, for diagnostic
evaluation. In all patients, POLR3Avariants were identified by
diagnostic whole exome sequencing, performed at different
centres. Segregation analysis established their biallelic occur-
rence in all patients except patient 6, of whom only one parent
was available for testing and carried one of the patient’s two
variants. No other variants were found explaining the move-
ment disorder. NIW saw patients 1, 3, 7–9; IKM saw patient 5,
AB patient 2, GB and RH patient 6, AR-P patient 4. Records
were reviewed for clinical presentation and are summarized in
Table 1; for case histories, see supplemental material.
The patients’ 18 cranial MRI scans (age at examination
0.5–29 years, mean 9.1 years, median 4.8 years) were system-
atically reviewed in consensus by a pediatric neuroradiologist
(IH) and pediatric neurologist (NIW). Axial T2-weighted
(T2w) and T1-weighted (T1w) images were available for all
MRI scans, sagittal T1w images for all but the follow-up MRI
in patient 6 (sagittal 3D-T2w), diffusion-weighted imaging
(DWI) with apparent diffusion coefficient (ADC) for at least
one MRI in all patients (13/18 MRIs). MRI was assessed for
presence and extent of T2w grey and white matter changes, in
particular for involvement of deep grey matter and brainstem
tracts, and for corresponding T1-signal changes. DWI and
ADC-maps were inspected for restricted diffusion, namely
hyperintensity on DWI and corresponding low signal on
ADC (below 60 × 10-5 mm2/s), or increased diffusion with
high signal on ADC (above 100–110 × 10-5 mm2/s, for basal
ganglia and white matter, respectively [13–15]).
T2 gradient echo and susceptibility-weighted images,
available for patient 9 and first MRIs of patients 1, 4, 5, and
6 (field strength 1.5 (2) or 3 Tesla(3)), were checked for
hypointensities due to calcifications and/or blood degradation
products; the cerebral CT scan available for patient 8 was
checked for hyperdensities. Spinal MRIs were available for
patients 1, 5, and 6.
For comparison of involvement of cerebellar peduncles
and/or striatum in typical 4H leukodystrophy, we additionally
reviewed 40MRIs of 36 patients with 4H leukodystrophy and
imaging between 2.8 and 40 years previously published [7].
Results
Patients
All patients except patient 5 had an extrapyramidal movement
disorder. Onset of symptoms varied between neonatal period
(patients 1–3), infancy (patients 4–6), and early childhood
(patients 7–9). Initial symptoms in the patients with neonatal
presentation comprised abnormal choreic movements, rest-
lessness, poor visual contact, failure to thrive due to
swallowing difficulties, and severe global developmental de-
lay. In the patients with infantile presentation, there were de-
velopmental delay more of motor than of cognitive develop-
ment and extrapyramidal signs with dystonic posturing and
poor facial expression (excepting patient 5 who had only mild
ataxia). In the patients with early childhood presentation, ini-
tial motor development was normal: All patients walked with-
out support age 12–15 months, although at least in patient 9
there were always concerns of frequent falls. In these patients,
both motor function and expressive speech deteriorated in
childhood with resulting severe dysarthria/anarthria and dys-
phagia. For a detailed description, see supplemental case re-
ports and Table 1.
Dentition was abnormal in six of nine patients. Of six pa-
tients tested, two had mild myopia (patients 5 and 9). Only
three patients (7–9) were old enough to exclude delayed pu-
berty due to hypogonadotropic hypogonadism. Clinical, ge-
netic, and MRI findings are summarized in Tables 1, 2, and 3
with patients sorted for age at first MRI.
Genetic findings
All patients carried at least one of two intronic variants of
POLR3A, c.1771-6C >G or c.1771-7C >G (Table 2; Fig. 1).
While the two brothers were homozygous for c.1771-6C >G,
all other patients were compound heterozygous: One patient
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carried the variant c.1771-6C >G, and six carried the variant
c.1771-7C > G in combination with another variant. These
were an intronic variant at/close to a splice site (n = 3; includ-
ing one with c.1771-6C >G), a synonymous variant predicted
to affect splicing (n = 1), and missense variants (n = 3). The
two missense variants were both located in the discontinuous
cleft domain and had not yet been described in patients. The
c.2045G >A variant (heterozygous) has been described in a
patient with classic 4H leukodystrophy [5]. The c.1048 +
5G > T variant in a homozygous state has been described in
a patient with Wiedemann-Rautenstrauch syndrome [16] and
compound heterozygous with c.1771-7C >G in a patient clas-
sified as spastic ataxia [12]. The c.1771-7C >G variant has
been found in patients classified as spastic ataxia, in combi-
nation with a frameshift variant [11, 12]. The c.1771-6C >G
variant has been described in patients in homozygous form
with basal ganglia involvement [10]. The c.4025-1G >A, pre-
viously not reported in literature, affects a canonical acceptor
site and can be considered as a loss-of-function variant.
MRI findings
Basal ganglia
Symmetric, homogeneous, mild T2-hyperintensity and atro-
phy of putamen and caudate nucleus (striatum) were present
in all patients (Fig. 2), with corresponding hyperintensity on
ADCmaps and increased ADC (range 110–120 × 10–5 mm2/
s) in those with diffusion-weighted imaging. Among the five
younger patients with first imaging until 2 years, the striatum
was already T2-hyperintense and atrophic in two patients at
0.9 and 1.0 year. In the other three, the striatum was initially
small or normal and had become T2-hyperintense and atro-
phic only by follow-up at 1.5, 4.8, and 2.9 years, respectively
(patients 4, 1, and 5; Figs. 3 and 4). The four older patients
imaged between 4 and 29 years all had striatal T2-
hyperintensity and atrophy (Table 3). In contrast, the striatum
was normal in the 36 patients with classic 4H leukodystrophy
re-reviewed for comparison.
The pallidum was not abnormally T2-hyperintense in our
pa t i en t s . I n t ho s e f i ve pa t i en t s w i t h g r ad i en t
echo/susceptibility-weighted images and in the CT scan of
patient 8, there was no indication of abnormal calcification,
iron deposition, or blood degradation products.
Cerebellum and brainstem
All patients had signal alterations of the superior cerebellar
peduncle (SCP) in at least one MRI, involving the decussation
in seven patients and reaching the red nucleus in two of these.
Additional findings were involvement of the hila of the den-
tate nuclei, the dentate nuclei, and/or the peridentate white
matter in six, three, and four patients, respectively, and of
the inferior cerebellar peduncle (ICP) in five. The middle cer-
ebellar peduncles (MCP) were involved in none. In contrast,
MCP were T2-hyperintense in 29, decussation of SCP in two,
and ICPwas not involved in any of the 36 patients with classic
4H leukodystrophy re-reviewed for comparison.
T2-hyperintensity of SCP did not significantly change in
patient 8 between 12 and 23 years, whereas it resolved in his
brother between 13 and 19 years (Fig. 5). Similarly, T2-
hyperintensity of SCP, hila of dentate nuclei, peridentate white
matter, and ICP clearly decreased in patient 5 between 2 and
4.8 years (Fig. 4). Conversely, infratentorial changes increased
in the youngest patient between 0.5 and 1.5 years: Only the
decussation of SCP was hyperintense at 0.5 years, while, at
follow-up, T2-hyperintensity involved the entire course of
SCP as well as the hila of the dentate nuclei, peridentate white
matter, and ICP (Fig. 5). Taken together, these findings sug-
gest that signal alteration of SCP, ICP, and dentate area may be
a transient phenomenon.
Supratentorial white matter
Signal of supratentorial white matter on T2w and T1w images
was normal in three of the four older patients examined be-
tween 4 and 29 years (patients 6–9), while mild T2-
hyperintensity of pyramidal tract in the centrum semiovale
and subcortical white matter was present in patient 9. The
Table 2 Genetic findings. Genetic variants for all patients
Patient Variant 1 Variant 2
1 c.1771-7C >G p.(Glu548_Tyr637del) / p.(Pro591Metfs*9) c.1048 + 5G > T p.(Glu350Glufs*27)
2 c.1771-7C >G p.(Glu548_Tyr637del) / p.(Pro591Metfs*9) c.4025-1G >A p.?
3 c.1771-7C >G p.(Glu548_Tyr637del) / p.(Pro591Metfs*9) c.2713G >A p.(Asp905Asn)
4 c.1771-7C >G p.(Glu548_Tyr637del) / p.(Pro591Metfs*9) c.3387C >A p.(Leu1129Leu)
5 c.1771-7C >G p.(Glu548_Tyr637del) / p.(Pro591Metfs*9) c.2809G >A p.(Glu937Lys)
6 c.1771-7C >G p.(Glu548_Tyr637del) / p.(Pro591Metfs*9) c.1771-6C >G p.(Pro591Metfs*9)
7 & 8 c.1771-6C >G p.(Pro591Metfs*9) c.1771-6C >G p.(Pro591Metfs*9)
9 c.1771-6C >G p.(Pro591Metfs*9) c.2045G >A p.(Arg682Gln)
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optic radiation was well myelinated, with T2w hyperintense
signal in the surrounding white matter.
In the five younger patients with first imaging up to the age
of 2 years, myelination was delayed and/or inhomogeneous
with progressing, more advanced, or normal myelination for
age outside of pyramidal and visual tracts: In the youngest
patient (patient 1), myelination was delayed at 0.5 years. By
follow-up at 1.5 years, myelination in the central region had
not progressed, and there was new T2-hyperintensity in cen-
trum semiovale, corona radiata, and visual tract, whereas
myelination was normal outside of pyramidal and visual tracts
(Supplemental Fig. 1). T2-hyperintensity of pyramidal tract
and/or optic radiation was also observed in patients 2–5, in
patient 5 with incomplete myelination of subcortical white
matter. Signal of the posterior limb of internal capsule, includ-
ing the pyramidal tract, was normal in all patients and no
patient had frank hypomyelination.
Pituitary gland, bulbi, atrophy, and spinal cord
The pituitary gland including T1-hyperintense signal of neu-
rohypophysis was normally visualized on sagittal T1w images
in all patients. No patients had clearly elongated bulbi as an
indicator of myopia, often seen in classic 4H leukodystrophy.
With regard to atrophy, corpus callosum was normal in eight
patients on visual inspection and thin in one patient (patient 3).
Cerebellar atrophy was not observed. Spinal cord was normal
in the three patients with spinal MRIs (patients 1, 5, and 6).
Discussion
We present nine patients with biallelic variants in POLR3A
carrying at least one of two intronic variants (c.1771-6C >G
or c.1771-7C >G), with predominantly extrapyramidal mani-
festations and characteristicMR changes of striatum, superior,
and, often, inferior cerebellar peduncle. Their neurological
presentation differs from classic 4H leukodystrophy, the ini-
tially described presentation of POLR3A variants. It also dif-
fers from a subform of spastic ataxia and the rareWiedemann-
Rautenstrauch syndrome (OMIM#264090), which have only
recently been associated with POLR3A. Clinical presentation
of these nine patients forms a continuum between a severe,
extrapyramidal movement disorder with early onset at one end
and juvenile parkinsonismwith onset in childhood at the other
end of the spectrum. Interestingly, six of the nine patients had
abnormal dentition comparable with the abnormal dentition
seen in 4H leukodystrophy. There was no evidence for endo-
crine involvement, although only three patients were old
enough to exclude delayed puberty due to hypogonadotropic
hypogonadism. Severe myopia, which occurs very frequently
Fig. 1 Localisation of variants and conservation in POLR3A. This figure
shows the localization of intronic variants (in blue) and exonic variants (in
red) in POLR3A. a Two missense variants are both located in the
discontinuous cleft domain, one in the pore domain. b denotes
conservation of mutated amino acids across different species. c Motifs
of primary sequence conservation surrounding the c.3387C base pair
based on alignment of 61 species using WebLogo, demonstrating the
high conservation of the c.3387C base pair. The observed variant
(c.3387C >A) does not lead to an amino acid change but is predicted to
activate an exonic cryptic acceptor site in exon 26
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Fig. 2 Characteristic MRI pattern of striatal variant of POLR3A-related
disease. MRI in patient 1 at 1.5 years demonstrates the characteristic
combination of atrophic, T2-hyperintense striatum ,and T2-hyperintense
SCP (A-E: T2w; F: ADC-map; insets: 1 = ICP, 2 = peridentate white
matter, 3 = SCP). a T2-hyperintensity of ICP (1) and peridentate white
matter (2) are additional findings. b Further additional findings are T2-
hyperintensity of tegmentum and intraparenchymal course of trigeminal
nerve. T2-hyperintensity of SCP (3, insets in B-D) is seen along its course
from the cerebellum (b), dorsal mesencephalon (c) to the decussation in
the anterior mesencephalon (d). e, f: Homogeneous, mild, and symmetric
T2-hyperintensity of the striatum with volume loss and increased
diffusion. NB the lateral medullary lamina between pallidum and
putamen is commonly seen at this age due to its relative T2-
hyperintensity compared with pallidum and putamen; increased
conspicuity is due to T2-hyperintensity of putamen (e)
Fig. 3 Small striatum and
infratentorial changes at first MRI
of patient 4. At 20 months, the
striatum is small (e, age-matched
control image in (f) for
comparison), but its signal does
not exceed that of the cortex and
is normal. Note involvement of
ICP (a), dentate nuclei, hila, and
peridentate white matter (b), and
of SCP including the decussation
(b–d)
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in children with 4H leukodystrophy and especially POLR3B
variants, was not present.
Although our patients share variants with the spastic ataxia
cohort (c.1771-7C >G; homozygous in several patients [12]),
none was clinically classified as spastic ataxia. Interestingly,
the original description of the patients homozygous for this
variant also mentions extrapyramidal features and early onset
of disease. And, while striatal changes are not mentioned,
FLAIR-hyperintensity along the superior cerebellar peduncles
was noted in almost all patients with the c.1909 + 22G >A
Fig. 4 Evolution of brainstem
and striatal changes in patients 1
(A, B) and 5 (C, D). A, In patient
1 at 0.5 years, the decussation of
SCP mildly hyperintense (A4;
inset: normal finding in age-
matched control) and the striatum
is normal (A5). B At 2 years ICP
(B1), hila of dentate nuclei and
peridentate white matter (B1,2) are
newly hyperintense, and SCP is
now clearly hyperintense along its
mesencephalic course (B3) and in
the decussation (B4). The striatum
is homogeneously T2-
hyperintense and atrophic (B5).
C Patient 5 also has a normal
striatum at 2 years (C5). ICP
(C1), hila of dentate nuclei,
peridentate white matter (C2) and
SCP (C3), along to the red nucleus
(C4) are T2-hyperintense. At
4.8 years (D), infratentorial
changes (D1–4) are regressing
whereas the striatum is newly
T2-hyperintense and atrophic
(D5)
Fig. 5 Striatal injury, regressing infratentorial changes, and normal
supratentorial white matter in patient 7 at 13.6 and 18.5 years. T2-
hyperintensity of inferior cerebellar peduncle (a, arrows in inset) and
outlining the mesencephalic course of superior cerebellar peduncles (b,
c; NB wide perivascular spaces in anterior mesencephalon) including
their decussation (d) at 13.6 years (a–f). This has resolved by
18.5 years (g–l). The striatum is shrunken and T2-hyperintense (k),
supratentorial white matter normal (including ADC, not depicted).
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variant, but, interestingly, not in the two patients homozygous
for the c.1771-7C > G variant [12]. They might thus also be
classified as the striatal variant ofPOLR3A-associated disease.
One variant seen in our cohort, c.1048 + 5G > T, has also been
found in spastic ataxia [12] and Wiedemann-Rautenstrauch
syndrome [16]. However, our patient did not have the intra-
uterine and marked postnatal growth retardation,
lipodystrophy, or distinctive facies characteristic of the
progeroid syndrome of Wiedemann-Rautenstrauch [17].
The two brothers (patients 7 and 8) with the previously
described, homozygous c.1771-6C > G variant [10], had a
presentation similar to that of the three initially described pa-
tients [10] with onset in childhood and severe dysarthria,
hypokinesia, and rigidity. A prominent, slow resting, and act-
ing tremor, also sometimes called rubral tremor, in addition to
severe dysarthria was seen in the older brother and in patient 9,
who carried the c.1771-6C >G variant in combination with a
missense variant.
The c.1771-6C >G variant was also described in one pa-
tient said to have spastic ataxia but also with dystonia [10, 11],
without detailedMRI information. In a publication on atypical
radiological findings in 4H leukodystrophy, one patient also
carried this variant in heterozygous form, and, in retrospect,
his last MRI showed small caudate and putamen with elevated
T2 signal in addition to the signal abnormalities in the poste-
rior limb of the internal capsule, fitting with his prominent
extrapyramidal symptoms [9]. Recently, a young child with
the c.1771-6C >G variant in trans with a frameshift variant
has been published; the MRI shows the typical basal ganglia
involvement described in this work, although this was not
recognized as abnormal [18].
Among the other six patients, clinical manifestation varied
despite sharing the c.1771-7C >G variant on one allele and
the three youngest patients (patients 1–3) were much more
severely affected than patients 4–6. The c.1048 + 5G > T var-
iant on the second allele in one severely affected patient has
been predicted to cause a frameshift with premature stop of
translation [16]. It can be classified as a loss-of-function var-
iant, similar to the variant found in patient 2 (c.4025-1G >A).
The c.1771-7C >G variant itself has been shown to lead to
two aberrant transcripts in addition to the normal cDNA,
interpreted as activating a leaky splice site with both wild-
type and aberrant transcripts [12]. Similar results were obtain-
ed for the c.1771-6C >G variant, with skipping of exon 14
and a premature termination of a part of the transcripts, with
the shorter transcript being subject to nonsense-mediated de-
cay [10].
Findings at brain imaging reflect the prominent extra-
pyramidal movement disorder: T2-hyperintensity and at-
rophy of the striatum were present in all patients, either
at first imaging or on follow-up. In one case, a small
striatum preceded T2-hyperintensity. A normal striatum
was not seen after onset of extrapyramidal movement
disorder. T2-hyperintensity was discrete and relatively
inconspicuous compared with striatal injury, e.g. in
glutaric aciduria type 1 or ischemia. Atrophy varied be-
tween mild and severe, e.g. in patients 1 and 7 (Figs. 2
and 5), similar to the initially described patients with
striatal injury and homozygous c.1771-6C > G variant
[10]. Extrapyramidal signs can also develop in classic
4H leukodystrophy [6], with visually normal basal gan-
glia on brain MRI.
The second characteristic MRI feature was involve-
ment of SCP, which was present in all our patients.
This included the dentate nucleus and/or its hilus as
the starting point of the efferent neurons of SCP in
six patients and the red nucleus as a relay station in
two of these. ICP was additionally involved in six pa-
tients. Involvement of SCP in patients with POLR3A
variants has previously been reported for the spastic-
ataxia cohort [12] and in four of eight atypical patients
[19]. It is also depicted in a report of a patient with
hypomyelination and a previously unreported homozy-
gous variant of c.2423G > A in exon 18 (Fig. 2a in
[20]). Involvement of the red nucleus as a relay station
of SCP was reported for the three patients homozygous
for the c.1771-6C > G variant [10]. The symmetric, an-
terior mesencephalic T2-hyperintensity also reported
might rather correspond to the superior mesencephalic
course of SCP than the proposed intraparenchymal
course of the oculomotor nerve [10].
Changes in SCP, dentate and red nuclei, and ICP
were not clearly associated with striatal injury since
they preceded striatal injury in two patients and were
subsequent in one. Moreover, their decrease and disap-
pearance in two patients suggest that they are a poten-
tially transient phenomenon. While SCP involvement in
the spastic-ataxia cohort was thought to represent the
structural correlate of the cerebellar manifestation [12],
contribution of SCP and ICP to the clinical picture in
our patients is difficult to pinpoint. This is due to the
predominantly extrapyramidal movement disorder, the
infrequent ataxia, and the unchanged presentation in
those patients with decreasing or resolving changes, al-
though the prominent tremor in patients 8 and 9 is
certainly compatible with the involvement of the stria-
tum and the dentate outflow tract [21].
Compared wi th c lass i c 4H leukodys t rophy,
infratentorial involvement was practically inverted in pa-
tients with the striatal variant of POLR3A-related dis-
ease: While MCP was normal in the striatal variant,
T2-hyperintensity of MCP has been noted in reported
cases of 4H leukodystrophy [22–24] and was present
in 29 of the 36 the previously reported patients with
classic 4H leukodystrophy [7] re-reviewed for compari-
son. SCP was involved in only two patients with classic
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4H leukodystrophy, but in all patients with the striatal
variant, ICP in none of the patients with classic 4H
leukodystrophy and in six of nine patients with the
striatal variant POLR3A-related disease. Moreover, T2-
hyperintensity of cerebellar white matter with relatively
T2-hypointense dentate nucleus and early cerebellar at-
rophy are common in 4H leukodystrophy [25], while
cerebellar signal changes in patients with the striatal
variant were restricted to dentate area, and cerebellar
atrophy was absent. In addition, none of the 36 patients
with classical 4H leukodystrophy re-reviewed for com-
parison had striatal T2-hyperintensity.
In 4H leukodystrophy, diffuse hypomyelination is a core
finding, commonly with some myelination of the visual
tract, the pyramidal tract in the posterior limb of the inter-
nal capsule, and the anterolateral thalamus [5, 25]. In con-
trast, myelination delay and white matter changes in our
patients preferentially involved the optic radiation and py-
ramidal tracts, and none had frank hypomyelination.
Thinning of corpus callosum, another common feature of
4H leukodystrophy, though somewhat less common in pa-
tients with carrying POLR3A variants [5], was only present
in one of the nine patients with the striatal variant.
In
Recognition of the characteristic MRI pattern, includ-
ing awareness of the potentially relatively mild T2-
hyperintensity and atrophy of the striatum, should trig-
ger genetic testing for POLR3A in patients with unex-
plained extrapyramidal movement disorders.
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